Article

Assessing feasibility and effectiveness of point-of-care limited HPV genotype tests in cervical cancer screening: a modelling study

2025-03-13

Abstract excerpt

<h4>Background</h4> Cervical cancer (CaCx) remains a significant cause of morbidity and mortality, especially among women in sub-Saharan Africa, where only 15% of women have undergone screening. To address these substantial screening gaps, the WHO recommends human papillomavirus (HPV) DNA detection as the primary screening method. One strategy to improve screening coverage is the use of limited HPV genotype targe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6e125084-46dd-568c-926b-0492434c51a0
DOI: 10.1101/2025.03.13.25323880

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessing feasibility and effectiveness of point-of-care limited HPV genotype tests in cervical cancer screening: a modelling studyDOI 10.1101/2025.03.13.25323880Read

Benefits, harms and cost-effectiveness of cervical screening and treatment in 78 low-income and lower-middle income countries for women in the general population: modelling to support updated WHO cervical screening and treatment guidelines to prevent cervical cancerSemantic proximity Read

Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana.Semantic proximity Read

Point-of-care HPV DNA testing for the early detection and treatment of cervical pre-cancer among women living with HIV in Papua New Guinea: a prospective clinical cohort studySemantic proximity Read

Accuracy of screening tests for cervical pre-cancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, ZambiaSemantic proximity Read

The budget impact of cervical cancer screening using HPV primary screening.Semantic proximity Read

Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women.Semantic proximity Read

Cost, cost-effectiveness and budget impact analysis of near point-of-care GeneXpert testing for STIs in South Africa: leveraging current capacity to address high prevalence of <i>Chlamydia trachomatis</i> , <i>Neisseria gonorrhoeae</i> and <i>Trichomonas vaginalis</i>Semantic proximity Read

Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screening.Semantic proximity Read

Human papillomavirus testing in cervical cancer screening.Semantic proximity Read

Cost-effectiveness of HPV-based versus VIA-based cervical cancer screening among women living with HIV in Masaka District, UgandaSemantic proximity Read

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.Semantic proximity Read

Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.Semantic proximity Read